Literature DB >> 11438737

A mouse model for adenovirus gene delivery.

T Tallone1, S Malin, A Samuelsson, J Wilbertz, M Miyahara, K Okamoto, L Poellinger, L Philipson, S Pettersson.   

Abstract

The cellular attachment receptor for adenovirus (Ad), Coxsackie adenovirus receptor (CAR), required for delivery of Ad into primary cells, is not present on all cell types, thus restricting Ad-gene delivery systems. To circumvent this constrain, a transgenic mouse has been generated that expresses a truncated human CAR in all tissues analyzed. These mice allowed efficient in vitro infections at low multiplicities into lymphoid, myeloid, and endothelial cells. Furthermore, in vivo administration of Ad-vectors results in infection of macrophages, lymphocytes, and endothelial cells. In addition, tail vein injection resulted in targeting of virus into previously inaccessible areas, such as the lung and the capillaries of the brain. The CAR transgenic mice will be useful for rapid functional genomic analysis in vivo, for testing the efficacy of gene therapy procedures or as a source of easily transducible cells.

Entities:  

Mesh:

Year:  2001        PMID: 11438737      PMCID: PMC35442          DOI: 10.1073/pnas.141223398

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  27 in total

1.  The coxsackievirus-adenovirus receptor protein as a cell adhesion molecule in the developing mouse brain.

Authors:  T Honda; H Saitoh; M Masuko; T Katagiri-Abe; K Tominaga; I Kozakai; K Kobayashi; T Kumanishi; Y G Watanabe; S Odani; R Kuwano
Journal:  Brain Res Mol Brain Res       Date:  2000-04-14

2.  Expression of the adenovirus receptor and its interaction with the fiber knob.

Authors:  R P Tomko; C B Johansson; M Totrov; R Abagyan; J Frisén; L Philipson
Journal:  Exp Cell Res       Date:  2000-02-25       Impact factor: 3.905

Review 3.  Cell receptors involved in adenovirus entry.

Authors:  G R Nemerow
Journal:  Virology       Date:  2000-08-15       Impact factor: 3.616

4.  Transgenic expression of the coxsackie/adenovirus receptor enables adenoviral-mediated gene delivery in naive T cells.

Authors:  Y Y Wan; R P Leon; R Marks; C M Cham; J Schaack; T F Gajewski; J DeGregori
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

Review 5.  Gene-modified dendritic cells for use in tumor vaccines.

Authors:  C J Kirk; J J Mulé
Journal:  Hum Gene Ther       Date:  2000-04-10       Impact factor: 5.695

6.  Comparison of lipid-mediated and adenoviral gene transfer in human monocyte-derived macrophages and COS-7 cells.

Authors:  H Heider; S B Verca; S Rusconi; R Asmis
Journal:  Biotechniques       Date:  2000-02       Impact factor: 1.993

7.  Expression of coxsackie adenovirus receptor and alphav-integrin does not correlate with adenovector targeting in vivo indicating anatomical vector barriers.

Authors:  H Fechner; A Haack; H Wang; X Wang; K Eizema; M Pauschinger; R Schoemaker; R Veghel; A Houtsmuller; H P Schultheiss; J Lamers; W Poller
Journal:  Gene Ther       Date:  1999-09       Impact factor: 5.250

8.  The dual impact of coxsackie and adenovirus receptor expression on human prostate cancer gene therapy.

Authors:  T Okegawa; Y Li; R C Pong; J M Bergelson; J Zhou; J T Hsieh
Journal:  Cancer Res       Date:  2000-09-15       Impact factor: 12.701

9.  Expression of a human coxsackie/adenovirus receptor transgene permits adenovirus infection of primary lymphocytes.

Authors:  M R Schmidt; B Piekos; M S Cabatingan; R T Woodland
Journal:  J Immunol       Date:  2000-10-01       Impact factor: 5.422

10.  Identification and isolation of endothelial cells based on their increased uptake of acetylated-low density lipoprotein.

Authors:  J C Voyta; D P Via; C E Butterfield; B R Zetter
Journal:  J Cell Biol       Date:  1984-12       Impact factor: 10.539

View more
  25 in total

Review 1.  Gene delivery into primary T cells: overview and characterization of a transgenic model for efficient adenoviral transduction.

Authors:  Vincent Hurez; Robin D Hautton; James Oliver; R James Matthews; Casey K Weaver
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

Review 2.  Adenovirus receptors.

Authors:  Yuanming Zhang; Jeffrey M Bergelson
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

3.  Targeting EGFR with metabolically biotinylated fiber-mosaic adenovirus.

Authors:  L Pereboeva; S Komarova; J Roth; S Ponnazhagan; D T Curiel
Journal:  Gene Ther       Date:  2007-01-25       Impact factor: 5.250

4.  A mouse model for HIV-1 entry.

Authors:  John Pietzsch; Henning Gruell; Stylianos Bournazos; Bridget M Donovan; Florian Klein; Ron Diskin; Michael S Seaman; Pamela J Bjorkman; Jeffrey V Ravetch; Alexander Ploss; Michel C Nussenzweig
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-10       Impact factor: 11.205

5.  Conditional gene recombination by adenovirus-driven Cre in the mouse uterus.

Authors:  Haibin Wang; Huirong Xie; Hao Zhang; Sanjoy K Das; Sudhansu K Dey
Journal:  Genesis       Date:  2006-02       Impact factor: 2.487

6.  Distinct Hippocampal Pathways Mediate Dissociable Roles of Context in Memory Retrieval.

Authors:  Chun Xu; Sabine Krabbe; Jan Gründemann; Paolo Botta; Jonathan P Fadok; Fumitaka Osakada; Dieter Saur; Benjamin F Grewe; Mark J Schnitzer; Edward M Callaway; Andreas Lüthi
Journal:  Cell       Date:  2016-10-20       Impact factor: 41.582

7.  Retargeting of gene expression using endothelium specific hexon modified adenoviral vector.

Authors:  Sergey A Kaliberov; Lyudmila N Kaliberova; Zhi Hong Lu; Meredith A Preuss; Justin A Barnes; Cecil R Stockard; William E Grizzle; Jeffrey M Arbeit; David T Curiel
Journal:  Virology       Date:  2013-10-15       Impact factor: 3.616

8.  Targeting of mesenchymal stem cells to ovarian tumors via an artificial receptor.

Authors:  Svetlana Komarova; Justin Roth; Ronald Alvarez; David T Curiel; Larisa Pereboeva
Journal:  J Ovarian Res       Date:  2010-05-25       Impact factor: 4.234

9.  Transduction of brain dopamine neurons by adenoviral vectors is modulated by CAR expression: rationale for tropism modified vectors in PD gene therapy.

Authors:  Travis B Lewis; Joel N Glasgow; Anya M Glandon; David T Curiel; David G Standaert
Journal:  PLoS One       Date:  2010-09-17       Impact factor: 3.240

10.  Characterization of the expression of key adenoviral receptors CAR and integrin beta3/beta5 subunits on the membrane of human NT2 neurons.

Authors:  Deqi Huang; Angele Desbois; Gao Chen; Hung Fang; Sheng T Hou
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.